US visitors, please note: This website contains information on the PROGENSA® PCA3 Assay which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or applicable in the USA. View details on US FDA approval for PROGENSA® PCA3 Assay.
The PCA3 gene is a prostate cancer-specific gene. It is present in much higher levels in prostate cancer tissue than in normal prostate tissue. The PCA3 Assay determines the likelihood of presence of cancer cells in the prostate